A randomized controlled trial of dihydroartemisinin-piperaquine, artesunate-mefloquine and extended artemether-lumefantrine treatments for malaria in pregnancy on the Thailand-Myanmar border

BACKGROUND: Artemisinin and artemisinin-based combination therapy (ACT) partner drug resistance in Plasmodium falciparum have spread across the Greater Mekong Subregion compromising antimalarial treatment. The current 3-day artemether-lumefantrine regimen has been associated with high treatment fail...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Med
Auteurs principaux: Saito, Makoto, Carrara, Verena I., Gilder, Mary Ellen, Min, Aung Myat, Tun, Nay Win, Pimanpanarak, Mupawjay, Viladpai-nguen, Jacher, Paw, Moo Kho, Haohankhunnatham, Warat, Konghahong, Kamonchanok, Phyo, Aung Pyae, Chu, Cindy, Turner, Claudia, Lee, Sue J., Duanguppama, Jureeporn, Imwong, Mallika, Bancone, Germana, Proux, Stephane, Singhasivanon, Pratap, White, Nicholas J., Nosten, François, McGready, Rose
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2021
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8191049/
https://ncbi.nlm.nih.gov/pubmed/34107963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-021-02002-8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires